1. Home
  2. SCLX vs FLUX Comparison

SCLX vs FLUX Comparison

Compare SCLX & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • FLUX
  • Stock Information
  • Founded
  • SCLX 2011
  • FLUX N/A
  • Country
  • SCLX United States
  • FLUX United States
  • Employees
  • SCLX N/A
  • FLUX N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • FLUX Industrial Machinery/Components
  • Sector
  • SCLX Health Care
  • FLUX Miscellaneous
  • Exchange
  • SCLX Nasdaq
  • FLUX Nasdaq
  • Market Cap
  • SCLX 35.7M
  • FLUX 30.0M
  • IPO Year
  • SCLX N/A
  • FLUX N/A
  • Fundamental
  • Price
  • SCLX $24.96
  • FLUX $2.78
  • Analyst Decision
  • SCLX Strong Buy
  • FLUX Strong Buy
  • Analyst Count
  • SCLX 3
  • FLUX 2
  • Target Price
  • SCLX $367.50
  • FLUX $6.00
  • AVG Volume (30 Days)
  • SCLX 205.7K
  • FLUX 581.6K
  • Earning Date
  • SCLX 08-13-2025
  • FLUX 09-16-2025
  • Dividend Yield
  • SCLX N/A
  • FLUX N/A
  • EPS Growth
  • SCLX N/A
  • FLUX N/A
  • EPS
  • SCLX N/A
  • FLUX N/A
  • Revenue
  • SCLX $44,236,000.00
  • FLUX $66,434,000.00
  • Revenue This Year
  • SCLX $89.26
  • FLUX $10.96
  • Revenue Next Year
  • SCLX $203.95
  • FLUX $12.78
  • P/E Ratio
  • SCLX N/A
  • FLUX N/A
  • Revenue Growth
  • SCLX N/A
  • FLUX N/A
  • 52 Week Low
  • SCLX $3.60
  • FLUX $1.15
  • 52 Week High
  • SCLX $39.90
  • FLUX $3.39
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 64.44
  • FLUX 71.28
  • Support Level
  • SCLX $22.45
  • FLUX $1.47
  • Resistance Level
  • SCLX $27.58
  • FLUX $3.31
  • Average True Range (ATR)
  • SCLX 2.32
  • FLUX 0.25
  • MACD
  • SCLX 0.09
  • FLUX 0.15
  • Stochastic Oscillator
  • SCLX 74.71
  • FLUX 71.47

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

Share on Social Networks: